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The host range activity of SV40 has been described as the inability of mutant viruses with deletions in the C terminal region of large T Ag to
replicate in certain types of African green monkey kidney cells. We constructed new mutant viruses expressing truncated TAg proteins and found
that these mutant viruses exhibited the host range phenotype. The host range phenotype was independent of acetylation of TAg at lysine 697. Co-
expression of the C terminal domain of T Ag (aa 627–708) in trans increased both T Ag and VP1 mRNA as well as protein levels for host range
mutant viruses in the restrictive cell type. In addition, the T Ag 627–708 fragment promoted the productive lytic infection of host range mutant
viruses in the nonpermissive cell type. The carboxyl-terminal region of T Ag contains a biological function essential for the SV40 viral life cycle.
© 2006 Elsevier Inc. All rights reserved.Keywords: Simian Virus 40; SV40; Host range; Large T Ag; SV40 replicationIntroduction
Simian Virus 40 large tumor antigen (SV40 T Ag) is a 708-
amino-acid multifunctional oncoprotein that is responsible for
many aspects of the SV40 viral life cycle. T Ag's biochemical
activities include SV40 origin binding, ATPase and helicase
activity (Fanning and Knippers, 1992). In addition, SV40 T Ag
is required for viral replication as well as virus-induced cellular
transformation. T Ag mediates many of its functions through
binding to several key cellular factors, most notably p53 and
pRb, that are required for T Ag's transforming ability (Ali and
DeCaprio, 2001). Many of the specific regions of TAg involved
in binding to cellular proteins as well as those domains within
the TAg molecule that contain TAg's functional activities have
been mapped. In addition, the SV40 T Ag protein has been
shown to be post-translationally modified by phosphorylation,
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doi:10.1016/j.virol.2006.01.046ribosylation, adenylation and, more recently, acetylation of a
specific lysine residue (Bradley et al., 1984; Goldman et al.,
1981; Jarvis and Butel, 1985; Klockmann and Deppert, 1983;
Paucha et al., 1978; Poulin et al., 2004; Tegtmeyer et al., 1977).
Four phosphorylation sites (serines 639, 677 and 679 and
threonine 701) and an acetylation site (lysine 697) have all been
identified within the extreme carboxyl-terminal domain of TAg
(Kress et al., 1982; Poulin et al., 2004; Scheidtmann et al., 1982,
1991; van Roy et al., 1983). The C terminus of SV40 T Ag
appears to be a highly modified region suggesting a complex
level of regulation. However, the exact function of the C
terminus is not well understood. It has been shown that the C
terminus of T Ag is not required for transformation since T Ag
1–627 is able to transform at wild-type levels (Tevethia et al.,
1988).
The only known biological function of the C terminal
domain of SV40 TAg is what has been previously characterized
as the host range/Adenovirus helper function (hr/hf). The host
range function of SV40 has been described as the inability of
SV40 mutant viruses with deletions in the C terminal region of
large T Ag (residues 627–708) to replicate in certain types of
African green monkey kidney cells (Pipas, 1985; Tornow and
Cole, 1983b; Tornow et al., 1985). Host range mutants of SV40
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CV-1 cells, but they can replicate and form plaques in BSC and
Vero cells. Because of this defect, CV-1 cells are known as
restrictive and BSC and Vero cells are known as permissive. In
addition, these mutant viruses exhibit a cold sensitive
phenotype where a shift in temperature of any of these cell
types to 32 °C makes multiplication of SV40 virions more
restrictive (Cole and Stacy, 1987; Pipas, 1985; Spence and
Pipas, 1994a). Wild-type SV40 can replicate and cause CPE in
all of these cell types and at any temperature. Similarly, the
adenovirus helper function is also attributed to this same C
terminal region of T Ag. Mutants lacking this domain of T Ag
are unable to rescue the growth of adenovirus in monkey cells,
while wild-type SV40 can (Cole and Stacy, 1987; Cole et al.,
1979; Heath et al., 1992; Polvino-Bodnar and Cole, 1982). It is
unclear whether the host range and adenovirus helper functions
of T Ag represent two separate functions or supply the same
activity.
Several studies have characterized the host range phenotype
of SV40 TAg. Viral DNA replication of the host range mutants
is not defective in the nonpermissive cell line, but the mutants
fail to form infectious particles (Pipas, 1985; Spence and Pipas,
1994a). The level of late viral mRNA and the synthesis of late
viral proteins (VP1 and VP3) are decreased by a factor of 5–15
for host range mutant viruses in restrictive cells (Khalili et al.,
1988; Stacy et al., 1989; Tornow et al., 1985). In addition, it has
been suggested that the defect of host range mutant viruses
occurs during viral assembly. Specifically, the association of
viral chromatin with the capsid proteins, VP1 in particular, and
the formation of assembly intermediates leading to mature
virions are blocked. The limiting step appears to occur with
loading of the capsid proteins and chromatin into viral particles
(Spence and Pipas, 1994a, 1994b).
There has been some speculation of the role of the 61-
amino-acid agnoprotein in the host range phenotype. While
the function of the agnogene product is not entirely
understood, there are some reports that the synthesis of
agnoprotein in SV40 host range mutants is severely impaired.
However, mutants of SV40 defective in agnogene expression
but produce wild-type T Ag are able to complement host
range mutants. In addition, while a CV-1 cell line that stably
expresses agnoprotein does support plaque formation of host
range mutant viruses, virus yield is not rescued to wild-type
levels. Furthermore, the expression of agnoprotein does not
rescue the defect of mRNA or capsid protein synthesis of host
range mutant viruses in the restrictive cell type (Spence et al.,
1990; Stacy et al., 1990). This indicates that, while decreased
expression of agnoprotein may be an effect of the host range
phenotype, it is not the cause.
The defect in viral multiplication of host range mutants in
CV-1 cells can be complemented in trans by SV40 viruses
containing a wild-type T antigen or any number of T antigen
mutants that contain deletions in regions other than the C
terminus (Pipas, 1985; Tornow and Cole, 1983a). Interest-
ingly, an inversion mutant of SV40 that exchanges the C
terminal 18 amino acids of VP1 with the C terminal 26 amino
acids of T Ag is a viable mutant (Fey et al., 1979; Tornow etal., 1985). Furthermore, a virus expressing this mutant protein
can complement a host range defective virus. This suggests
that the C terminal domain of SV40 T Ag possesses a
separable functional activity that is required for viral
multiplication.
In this report, we tested the role of T Ag acetylation in
SV40 host range function. In addition, we generated three
new host range mutant viruses by introducing single
nucleotide point mutations into the SV40 genome. We show
that these mutants were defective for plaque formation in the
restrictive cell type. These new mutants, in addition to classic
host range mutants, had reduced expression of both T Ag and
VP1 protein as well as T Ag and VP1 mRNA measured by
real-time PCR in CV-1P cells. We were able to complement
host range mutant viruses through the expression of the C
terminal domain of T Ag (amino acids 627–708) as an HA-
tagged fragment in trans. The carboxyl-terminal region of T
Ag is a separable functional domain that is essential for the
SV40 viral life cycle.
Results
The host range activity of SV40 is independent of T Ag
acetylation
To test the possibility that the acetylation of SV40 T Ag on
lysine 697 is required for host range function, we introduced
lysine to arginine (to conserve the positive charge) and lysine
to glutamine (to mimic constitutive acetylation) amino acid
point mutations at position 697 into the genome of SV40
(K697R and K697Q, respectively) (Li et al., 2002; Poulin et
al., 2004). We also generated a control point mutation at the
adjacent unmodified lysine 698 (K698R) and a double point
mutant at both lysines (K697, 698R). In addition to
acetylation site mutants, we tested several other T Ag C
terminal mutant viruses for host range activity. T701A is a T
Ag C terminal phosphorylation site mutant previously
characterized to be able to replicate in CV-1P cells (Schneider
and Fanning, 1988). dl1263 is a T Ag C terminal deletion
mutant containing an internal deletion of amino acids 663 to
674 that has been shown to retain host range function (Cole et
al., 1979; Polvino-Bodnar and Cole, 1982). dl1066 lacks T
Ag amino acids 671 to 708 and contains an additional eight
amino acids (QKTSHTSP) inserted after residue 670. It has
been demonstrated that dl1066 displays the classic host range
phenotype and cannot replicate in CV-1P cells (Pipas, 1985;
Pipas et al., 1983). All of these viruses were grown and
titered on BSC40 cells.
Viruses were then tested alongside wt SV40 for their ability
to form plaques in CV-1P (restrictive) cells compared to BSC40
(permissive) cells at 37 °C. Two hundred plaque forming units
(pfus) of each virus were used to infect confluent 60 mm dishes
of CV-1P and BSC40 cells in duplicate and assayed for their
ability to undergo lytic viral replication by plaque assay. Results
for duplicate dishes of three independent experiments are
summarized in Fig. 1. As expected, wt SV40 produced
approximately 200 plaques of comparative size in both cell
Fig. 1. The host range activity of SV40 is independent of TAg acetylation. Two
hundred plaque forming units (pfus) of wt SV40, dl1066, dl1263, T701A,
K697R, K697Q, K698R, and K697,698R viruses were used to infect confluent
dishes of BSC40 and CV-1P cells. Plaque formation was scored for each plate
after 8 days. Black bars indicate the number of plaques produced in BSC40 cells
while white bars show the number of plaques formed in CV-1P cells. Note that
dl1066 produced no plaques in CV-1P cells. This graph represents the
cumulative results of three independent experiments, with dishes of each cell
type infected in duplicate within each experiment.
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and BSC40 cells. In contrast, the dl1066 host range mutant was
completely defective for plaque formation in CV-1P cellsFig. 2. Viruses with TAg C terminal truncations exhibit the SV40 host range phenotyp
The C terminal 81 residues of SV40 TAg (628–708) are indicated by amino acid (aa
New host range mutants HR 627, HR 669 and HR 684 were constructed by introduci
at the positions indicated by black circles (residue 628 for HR 627, 670 for HR 669 an
bars) while leaving the remaining viral genomic DNA intact (dashed lines). Deletions
are also depicted for reference. (B) SV40 mutants HR 627, HR 669 and HR 684 are d
mutant viruses were used to infect confluent dishes of BSC40 and CV-1P cells. Plaque
of plaques produced in BSC40 cells while white bars show the number of plaques falthough it produced the expected number of 200 plaques in
BSC40 cells. The two other control viruses, dl1263 and T701A,
also behaved as expected, replicating to wild-type levels in both
the restrictive and permissive cell types. Mutation of the
acetylation site lysine at position 697 or the unmodified
adjacent lysine 698 did not affect the ability of SV40 to
replicate in restrictive cells. There was no significant difference
in the number of plaques produced in CV-1P and BSC40 cells
by acetylation site mutants.
Viruses with T Ag C terminal truncations exhibit the SV40 host
range phenotype
In order to systematically evaluate the region of the SV40
T Ag C terminus required for host range, we generated a
series of viruses containing truncations in their T Ag proteins.
We introduced single nucleotide point substitutions that
resulted in changing a T Ag amino acid to a stop codon
while leaving the remainder of the viral genomic DNA intact.
HR 627 produces a truncated T Ag protein that is 627 amino
acids long, while HR 669 and HR 684 express T antigens that
are 669 and 684 residues in length, respectively (Fig. 2A).
Virus stocks were produced and titered on BSC40 cells, and
then the viruses were evaluated for their ability to form
plaques in CV-1P cells by plaque assay as in Fig. 1 (Fig. 2B).e. (A) Schematic representation of mutations in TAg carboxyl-terminal domain.
) position and corresponding nucleotide (nt) position on the SV40 viral genome.
ng single nucleotide point mutations changing amino acid codons to stop codons
d 685 for HR 684). This resulted in truncated TAg proteins (represented by gray
(black line) and insertions (amino acids) contained in mutants dl1263 and dl1066
efective for plaque formation in CV-1P cells. Two hundred pfus of wt SV40 and
formation was scored for each plate after 8 days. Black bars indicate the number
ormed in CV-1P cells.
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BSC40 and CV-1P cells. In contrast, while the three new
mutant viruses (HR 627, HR 669 and HR 684) producedFig. 3. Host range mutant viruses have decreased TAg and VP1 protein expression in
terminus in trans. (A) TAg and VP1 protein expression is reduced for host range muta
was transfected into BSC40 and (B) CV-1P cells. Cells were stained with specific anti
of the TAg C terminus (T 627–708) in trans rescues early and late viral protein produ
T 627–708 and viral DNA and treated as in panel B.close to the expected number of plaques (200) in BSC40
cells, all three viruses had significantly reduced abilities to
form plaques in CV-1P cells.the restrictive cell type that can be rescued by expression of the TAg carboxyl-
nt viruses in CV-1P cells. Viral DNA for HR 627, HR 669, HR 684 and wt SV40
bodies for TAg and VP1 and visualized by immunofluorescence. (C) Expression
ction for host range mutants in CV-1P cells. CV-1P cells were co-transfected with
Fig. 4. T Ag and VP1 protein levels are reduced for host range mutants and can
be rescued by co-expression of T 627–708 in trans. (A) Host range mutants
produce less T Ag and VP1 compared to wt SV40. Viral DNA for HR 627, HR
669, HR 684 and wt SV40 was transfected into BSC40 and CV-1P cells. Lysates
from these cells were Western blotted using antibodies specific to TAg (top) and
VP1 (middle). A Western blot for vinculin (bottom) was done as a loading
control. (B) Expression of the T Ag C terminus (T 627–708) in trans increases
early and late viral protein production for host range mutants in CV-1P cells.
CV-1P cells were co-transfected with T 627–708 and viral DNA, and Western
blotting was done as in panel A. In addition, lysates were Western blotted using
an anti-HA antibody to detect the C terminal fragment of TAg, T 627–708 (third
from top).
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protein expression in the restrictive cell type that can be
rescued by expression of the T Ag carboxyl-terminus in trans
In order to determine the levels of SV40 early and late
protein expression for wild-type and host range mutant viruses
in permissive and restrictive cells, we performed co-immunos-
taining experiments for SV40 T Ag and VP1 (Figs. 3A and B).
BSC40 and CV-1P cells were transfected with wt SV40, HR
627, HR 669 or HR 684 viral DNA. Four days post-transfection,
cells were fixed and stained with specific antibodies to TAg and
VP1 and visualized.
In both BSC40 and CV-1P cells, wt SV40-transfected cells
showed specific T Ag staining in approximately 75% of cells
observed. VP1 staining was also brightly visible, although in
slightly fewer cells relative to TAg (about 40–50%) depending
on the stage of viral replication within the cell since VP1 is
expressed late in the SV40 life cycle. Host range mutants have
comparable expression of TAg and VP1 to wt SV40 in BSC40
cells (Fig. 3A). However, in CV-1P cells, the host range
mutants HR 627, HR 669 and HR 684 had markedly reduced
levels of both T Ag and VP1 that were below the limits of
detection (Fig. 3B). This is in striking contrast to wt SV40 in
CV-1P cells. Protein stability of HR 629, HR 669 and HR
684 T antigens was not significantly different from wt T Ag
when infected cells were treated with cyclohexamide (data not
shown).
Since other SV40 viruses that contain an intact carboxyl-
terminal domain of T Ag are able to complement the defect of
host range mutant viruses, we sought to complement host range
mutants by the expression of the C terminus of SV40 T Ag in
trans. We constructed an HA-tagged fragment containing the C
terminal 82 amino acids of SV40 TAg (residues 627–708) and
co-expressed this fragment with wt SV40 or host range mutant
viral DNA in CV-1P cells (T 627–708). Western blotting using
a T Ag acetylation site-specific antibody for lysine 697 (Poulin
et al., 2004) showed that T 627–708 expressed in trans was not
acetylated (data not shown). However, T 627–708 may
become phosphorylated since lambda-phosphatase treatment
caused the collapse of the upper band of the doublet typically
seen in Western blots for HA-tagged T 627–708 (data not
shown).
As shown in Fig. 3C, co-expression of T 627–708 increased
the levels of both early and late viral proteins for the HR 627,
HR 669 and HR 684 host range mutant viruses in the restrictive
cell type. While T 627–708 did not rescue mutant protein levels
to wild-type levels (90% T Ag cell staining for wt SV40
compared to 40–50% TAg staining for host range mutants), the
increase was substantial in relation to TAg and VP1 expression
for mutant viruses in CV-1P cells without the co-expression of T
627–708 (Fig. 3B).
Differences in viral protein expression between wt SV40 and
host range mutant viruses in BSC40 and CV-1P cells were
confirmed by Western blot. Cells were transfected with viral
DNA as for Fig. 3. Cells were harvested 4 days post-transfection
and total protein levels of whole cell extracts were analyzed. T
Ag and VP1 protein levels for dl1066, HR 627, HR669 andHR684 mutants were all reduced compared to wt SV40 in both
BSC40 and CV-1P cells. However, this decrease was much
more drastic in CV-1P cells (Fig. 4A). Consistent with our
immunofluorescence data, co-transfection of T 627–708 along
with viral DNA in the restrictive cell type distinctly increased
both TAg and VP1 expression for host range mutants in relation
to wt SV40 (Fig. 4B).
Host range mutant viruses have reduced T Ag and VP1 mRNA
levels in CV-1P cells that can be complemented by T 627–708
in trans
To determine if the differences in viral protein expression of
host range mutants seen by immunofluorescence and Western
blot analyses (Figs. 3 and 4) were due to reduced levels of
messenger RNA, we performed quantitative real-time reverse-
transcriptase PCR to quantify early and late viral mRNA
production. Viral DNAwas transfected as for Figs. 3 and 4, cells
were harvested 4 days later and RNA was made from cell
extracts. mRNA was quantified using real-time reverse-
transcriptase PCR with T-Ag- and VP1-specific primer–probe
sets as well as β-actin as a control. The T Ag primer–probe set
was designed to detect nucleotides located within the p53-
Fig. 5. Host range mutant viruses have reduced TAg and VP1 mRNA levels in
CV-1P cells that can be complemented by T 627–708 in trans. (A) Co-
expression of T 627–708 with host range mutants in CV-1P cells increases TAg
mRNA levels. Viral DNA alone for dl1066, HR 627, HR 669, HR 684 and wt
SV40 (white bars) or viral DNA plus T 627–708 (black bars) was transfected
into CV-1P cells. mRNA was quantified using reverse-transcriptase real-time
PCR by Taqman assay with a T-Ag-specific primer–probe set as well as β-actin
as a control. Results were normalized to wt SV40 (value set at 1) for comparison
between viruses. The graph shows triplicate samples from a representative
experiment. (B) VP1 mRNA of host range mutants is increased by co-
transfection of T 627–708. Same experiment as panel A using a VP1-specific
primer–probe set for real-time PCR analysis.
Fig. 6. The T Ag C terminus T 627–708 expressed in trans promotes the
productive lytic replication of host range mutants in CV-1P cells. Viral DNA for
dl1066, HR 627, HR 669, HR 684 and wt SV40 was transfected into BSC40
(white bars) and CV-1P cells (black bars). CV-1P cells were also co-transfected
with viral DNA plus the C terminal fragment of T Ag, T 627–708 (gray bars).
Upon onset of CPE (7 to 10 days later), the remaining cell monolayer was
stained with crystal violet. Dye absorption was quantified by measuring optical
density as an indicator of lysis of the cell monolayer and normalized to mock
values. The graph depicts the fraction of the cell monolayer that was lysed for
each virus in each cell type. The fraction of the monolayer lysed in mock-
infected cells was approximately zero, reflecting no cell lysis, while wt SV40
was approximately one, indicating near-complete destruction of the monolayer
in all cell types.
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627–708 expressing plasmid as well as to avoid possible
contamination of PCR reactions from other SV40-containing
plasmid DNA (Lopez-Rios et al., 2004). The VP1 primer–probe
set was designed to detect VP1-unique coding sequence (see
Materials and methods for exact primer–probe sequences).
Quantitative PCR analysis showed that T Ag and VP1
mRNA levels for host range mutants dl1066, HR 627, HR 669
and HR684 were reduced more than 10-fold compared to wt
SV40 early and late viral mRNA levels in CV-1P cells (Figs.
5A and B, white bars). However, when the C terminus of TAg,
T 627–708, was co-expressed with the host range mutant
viruses, mRNA levels for both T Ag and VP1 were
significantly rescued to levels approaching or even surpassing
(T Ag mRNA for dl1066 and HR 669) wt SV40 mRNA (Figs.
5A and B, black bars). β-actin levels were not significantly
changed in CV-1P cells regardless of type of DNA transfected
(data not shown).The T Ag C terminus T 627–708 expressed in trans promotes
the productive lytic infection of host range mutants in CV-1P
cells
In addition to mRNA and protein expression of VP1 and T
Ag, we wanted to determine if the C terminal fragment of T Ag
(T 627–708) could rescue the ability of host range mutants to
undergo a productive lytic cycle of viral replication in the
restrictive cell type. To test this, viral DNAwas transfected into
BSC40 and CV-1P cells. In addition, viral DNA was co-
transfected with T 627–708 in CV-1P cells and the cells were
monitored for cytopathic effect (CPE) as an indicator of a
productive viral replication cycle. When wt SV40-transfected
cells had undergone near-complete lysis of the cell monolayer
(7 to 10 days later), the cells were stained with crystal violet and
absorption of the dye was quantified to measure the fraction of
the cell monolayer that had been lysed due to CPE.
Fig. 6 depicts the results of these experiments as a bar graph.
While wt SV40 induced almost complete destruction of the
monolayer from CPE in both BSC40 and CV-1P cells, host
range mutants dl1066, HR 627, HR 669 and HR 684 produced
little to no CPE in CV-1P cells (black bars) although they were
able to induce CPE in BSC40 cells (white bars). Co-expression
of T 627–708, the carboxyl-terminal domain of T Ag, in trans
promoted the ability of host range mutants to undergo
productive viral replication and cause CPE in CV-1P cells,
lysing the cell monolayer (gray bars). When T 627–708 was co-
expressed, host range mutants were able to induce cytopathic
effect in the restrictive cell type to levels approaching (HR 627),
equal to (dl1066) or surpassing (HR 669 and HR 684) CPE
produced by these mutants in the permissive cell type.
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While many domains of SV40 T Ag have been well
characterized for TAg function or binding to important cellular
factors, the role of the C terminus of TAg (residues 627–708) is
less well understood. The large number of post-translational
modifications (four phosphorylation sites and one acetylation
site) in the carboxyl-terminus of TAg suggests that this domain
of T Ag may be highly regulated and thus serve an important
function for the virus. Indeed, the C terminus of T Ag has been
shown to encode the host range domain, a region required for
the productive infection of SV40 in certain types of African
green monkey kidney cells. In this study, we further explore the
function of the C terminal domain of T Ag in the SV40 life
cycle. Previous work in our laboratory identified a specific p53-
dependent site of acetylation at lysine 697 in the carboxyl-
terminus of SV40 TAg. Since the host range/Adenovirus helper
function (hr/hf) is the only biological function that has been
mapped to the C terminus, we were interested in testing the
effect of acetylation on viral replication of SV40. However, we
saw no effect of mutation of the T Ag acetylation site at lysine
697 or phosphorylation site at threonine 701 on the host range
phenotype of SV40 (Fig. 1). This is consistent with a previous
report demonstrating the ability of SV40 mutant T701A to
undergo viral replication in CV-1P cells at wild-type levels
(Schneider and Fanning, 1988).
While post-translational modification of the T Ag molecule
does not appear to play a role in the host range function of
SV40, the introduction of single nucleotide point mutations
disrupting the coding sequence of T Ag to produce truncations
at amino acids 627, 669 and 684 resulted in a loss of the ability
to undergo viral replication in CV-1P cells (Fig. 2). This is
similar to results seen with several other C terminal truncation
mutants that were previously characterized as host range
mutants such as dlA2465 (aa 627–708 deleted), dlA2459 (aa
674–708 deleted), dlA2476 (aa 683–708 deleted) and dl1066
(aa 671–708 deleted) (Cole and Stacy, 1987; Pipas, 1985).
Furthermore, the results from our three independent mutants
indicate that the host range function of T Ag may reside in its
very C terminal 25 amino acids. Interestingly, this region is
highly conserved with the BK and JC human polyomavirus T
antigens (Pipas, 1992). It is possible that this conserved region
serves a common purpose regulating viral replication for all
three viruses. Others have suggested that the host range function
of T Ag may reside in its C terminal 38 amino acids with
residues 673–699 playing an especially important role (Cole
and Stacy, 1987; Pipas, 1985). Additional point mutants in this
region may be useful in resolving these differences as well as
further identifying key residues responsible for the host range
function of SV40.
In our study, the defects seen in T Ag and VP1 protein and
mRNA expression were alleviated by the co-expression of T
627–708 (Figs. 3–5). Due to the nature of the organization of
the SV40 genome in overlapping reading frames, it is possible
that our primer–probe sets would detect alternate transcripts of
small T Ag, VP2 or VP3 that are not transcribed. Even if this
were the case, the RT-PCR assay would still measuretranscription from the two independent promoters, early and
late, of the virus. It is possible that the reduced T Ag and VP1
mRNA levels seen by real-time PCR are the result of a defect in
viral RNA processing. Improper splicing or capping of viral
mRNAs would result in immediate degradation of the RNA and
lower levels of detectable mRNA by real-time PCR. In this case,
T 627–708 may play a role in binding to RNA processing
factors or regulating the cellular RNA processing machinery.
Furthermore, it is possible that the RNA transcript itself
encoding T 627–708, rather than the protein, could stabilize the
viral RNA or otherwise promote increased transcription of the
viral RNA. Further studies are needed to explore this possibility.
A recent report has identified a micro-RNA molecule in the
SV40 genome that is located in the 3′ end of the TAg sequence,
in the region coding for the carboxyl-terminal domain (Sullivan
et al., 2005). The miRNA is thought to function to aide in
evasion of the host immune response to SV40 viral infection. It
occurred to us that, by introducing nucleotide point mutations,
we might be disrupting the miRNA structure, and this may be
causing the defect in virus multiplication in CV-1P cells that we
were seeing in the host range mutants. However, of the three
independent single nucleotide point mutations, two are located
outside of the miRNA region and only one (HR 669) is
contained within the miRNA. Since all three mutant viruses
displayed similar host range activity, it is unlikely that the
introduced mutation significantly affected the miRNA function.
Furthermore, a mutant SV40 virus that has a non-functional
miRNA produces unusually high levels of T Ag protein
(Sullivan et al., 2005). In the event that the mutation had
disrupted the miRNA structure, we would have expected to see
higher levels of T Ag, not lower, as we have seen with the host
range mutants (Figs. 3 and 4).
Previous studies of host range mutant viruses have reported
near-wild-type levels of viral DNA replication, thus attributing
the host range phenotype to a post-replicative block in the virus
life cycle (Pipas, 1985; Spence and Pipas, 1994a). In this study,
we did not test DNA replication of the host range mutants.
Therefore, we are unable to rule out the possibility that defects
in viral DNA replication contributed to the reduced mRNA and
protein levels observed for T Ag and VP1. However, the DNA
binding, ATPase and helicase domains of TAg are all located N
terminal of the region involved in host range activity (aa 627–
708) and thus it is unlikely that these functions of T Ag are
perturbed in host range mutants.
Since it has yet to be determined whether or not the SV40
host range and adenovirus helper functions are genetically
separable activities, it is unclear whether the results presented in
this report are applicable to the adenovirus helper function. Our
experiments tested only the host range function of SV40.
Further studies testing the ability of T 627–708 as well as the
mutant viruses generated in this report to complement the
growth of adenoviruses in monkey cells are needed to confirm
the potential role of our findings for the adenovirus helper
function.
Our results show that the carboxyl-terminal fragment of TAg
expressed in trans complements the viral replication defect of
host range mutants in the restrictive cell type (Fig. 6). It is
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life cycle through binding to another protein. However, that
protein is not likely to be a viral protein. We were unable to
detect complex formation between T 627–708 and either full-
length T Ag or VP1 by immunoprecipitation experiments (data
not shown). Therefore, it is not likely that the C terminus of T
Ag is heterodimerizing with the N terminal portion of T Ag in
this case, although there have been some reports suggesting that
the N and C terminal domains of TAg may form intramolecular
contacts (Weisshart et al., 2004). In addition, we have not seen
any evidence of integration of T 627–708 into the mutant viral
genome or formation of fusion proteins either by gel migration
or by IP Western (data not shown).
It is likely that T 627–708 mediates its effects on viral
replication through binding to a cellular protein. However, little
is known about the possible cellular binding partners in the C
terminus of SV40 T Ag. Recently, a report has described the
interaction of SV40 T Ag with Fbw7 (Fbxw7) (Welcker and
Clurman, 2005). It is thought that T Ag binds to Fbw7 through
its C terminal 10 amino acids and that this interaction depends
on the phosphorylation of T Ag at threonine 701. However, T
Ag binding to Fbw7 has not been shown to be essential for any
of TAg's functions (Welcker and Clurman, 2005). Furthermore,
the T701A SV40 mutant is wild-type for viral replication in a
host range assay indicating that any interaction of T Ag with
Fbw7 is not involved in the host range function of TAg (Fig. 1,
Schneider and Fanning, 1988).
T 627–708 may provide the host range function of SV40
through binding to an unknown cellular protein. This protein
could be an activating protein such as a transcription factor
necessary for viral protein production, thus facilitating the
formation of new virions. Conversely, the C terminus of T Ag
may act to sequester repressor molecules by binding to or
redirecting them, allowing the expression of viral proteins and
virus multiplication. It is likely that, whatever the cellular
protein is, it may be present in both BSC40 and CV-1P cells, but
protein affinities or concentrations may account for the
differences seen in the host range phenotype. In addition, host
range mutants are also cold-sensitive for viral replication in
some AGMK cells (Cole and Stacy, 1987). This is consistent
with the idea that necessary protein–protein interactions may
need to form in order for viral replication to take place, but these
interactions may become unstable upon temperature shift, thus
blocking the cycle of SV40 replication. The degree to which
these complexes are formed may need to reach a critical level
before SV40 undergoes a productive lytic infection. Future
experiments exploring cellular interacting proteins with the
carboxyl-terminus of T Ag should provide insight into the
nature of the SV40 host range phenotype as well as the role of
the C terminus in SV40 replication.
Materials and methods
Cells
African green monkey kidney (AGMK) cell lines BSC40,
supplied by J. Pipas (University of Pittsburgh), and CV-1P(Mertz and Berg, 1974) were cultured in Dulbecco's modified
Eagle's medium (DMEM) (Cellgro) supplemented with 10%
Fetal Clone-I serum (HyClone), 100 U of penicillin/mL and
100 μg of streptomycin/mL. CV-1P and BSC40 cells were
transfected using Lipofectamine Plus reagent (Invitrogen)
according to the manufacturer's protocol.
Plasmids
SV40 genomic DNA (strain 776) was cloned into the BamHI
site of pBluescript KS (Stratagene) for propagation. The SV40
K697Q, K697R, K698R, K697,698R, T701A, HR 627, HR 669
and HR 684 mutants were generated by PCR mutagenesis of the
wild-type SV40 genome using the Stratagene Quick Change kit
according to the manufacturer's protocol with appropriate
primers and sequence verified. HR 627 contains a single
nucleotide point substitution of C to T at nt 2934 of the SV40
genome resulting in a change of tryptophan 628 to a stop codon
(TGG to TGA). HR 669 substitutes G to C at nt 2804 replacing
serine residue 670 with a stop codon (TCA to TGA). HR 684
changes the G to A at nt 2765 resulting in replacement of
glutamine 685 with a stop codon (CAG to TAG). SV40
genomic DNA for the mutant virus dl1263 was provided by C.
Cole (Dartmouth College). The T Ag carboxyl-terminal
fragment was constructed by cloning T Ag residues 627–708
in frame with an N terminal influenza virus hemagluttinin (HA)
epitope (YPYDVPDYA) tag and the SV40 nuclear localization
signal (NLS) (SPKKKRKVED) in the pcDNA3 expression
vector (Invitrogen).
Viruses
Wild-type and mutant SV40 virus stocks were prepared by
excision of the viral genome from pBluescript KS by digestion
with BamHI and re-circularization of the viral genome by
ligation overnight at 16 °C. Viral DNAwas then transfected into
BSC40 cells. Upon near complete lysis of the cell monolayer by
cytopathic effect (7–10 days later), the cells were put through
three freeze–thaw cycles and cellular debris was spun out by
centrifugation. The remaining supernatant was used as the viral
stock and was subsequently titered by plaque assay on BSC40
cells. The dl1066 mutant virus was provided by J. Pipas
(University of Pittsburgh).
Plaque assays
SV40 plaque assays were carried out in duplicate as
previously described (Tremblay et al., 2001). Briefly, confluent
60 mm dishes of either BSC40 or CV-1P cells were infected
with the appropriate amount of virus in a total of 1 mL DMEM
containing 2% serum. Infection was allowed to proceed for 2 h
at 37 °C with rocking every 15 min. After 2 h, the virus was
aspirated and the cells were overlaid with 4 mL of a 1:1 mixture
of melted 1.8% BactoAgar (BD Biosciences) cooled to 45 °C
and 2× modified Eagle's medium (MEM) without phenol red
containing 10% serum at 37 °C. The dishes were refed every 3
days with 3 mL 1:1 agar:MEMmixture until day 6 when neutral
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mL. Plaques were visualized and counted on days 7–10. All
plaque assays were carried out at 37 °C.
Antibodies
The following antibodies were used for Western blot
analysis: anti-T Ag mouse monoclonal antibody 419 (Harlow
et al., 1981), anti-HA HA-11 (Covance), and anti-VP1
monoclonal antibody supplied by N. Christensen (Pennsylvania
State University). In addition, anti-T Ag rabbit polyclonal
antibody sc-20800 (Santa Cruz Biotechnology, Inc.) was used
for immunofluorescence along with the mouse monoclonal anti-
VP1 antibody.
Western blots
Whole cell lysates (75 μg) were separated in 5–20% SDS-
polyacrylamide gels and transferred to nitrocellulose mem-
branes (Bio-Rad). Membranes were blocked in 5% milk in
TBS-T (10 mM Tris–HCl [pH 8.0], 150 mMNaCl, 0.1% Tween
20) for at least 1 h at room temperature prior to incubation with
the appropriate antibody in TBS-T for 2 h at room temperature.
Detection of proteins was performed with the appropriate
horseradish-peroxidase-conjugated secondary goat antibody
(Pierce) at a 1:2500 dilution in TBS-T containing 0.5% goat
serum. Immunoblots were developed using enhanced chemilu-
minescence (Pierce) according to the manufacturer's protocol.
Immunofluorescence
Cells were cultured and transfected on glass coverslips. Four
days post-transfection the coverslips were washed three times
with phosphate-buffered saline (PBS) and fixed with 10%
buffered formalin acetate for 30 min. The cells were washed
with PBS three times, blocked with PBS-buffered 0.5% Triton
X-100 containing 3% goat serum for 20 min, and exposed to
primary antibodies for 1.5 to 2 h. After being washed three
times with PBS, cells were treated with a mixture of fluorescent-
labeled secondary antibodies and 5 μg of 4′,6-diamidino-2-
phenylindole (DAPI) per mL for 25 min. Fluorescent images
were obtained by using Nikon Eclipse E800 and a Spot digital
camera (Diagnostic Instruments, Inc.).
RNA expression analysis
Cells were transfected with viral DNA in 100 mm dishes.
Four days post-transfection, cells were harvested and RNAwas
made using an RNEasy kit (Qiagen). cDNAwas made using BD
Sprint PowerScript PrePrimed Single Shots (BD Biosciences).
Real-time PCR quantification of TAg and VP1 gene expression
was performed in triplicate using Taqman probes and an ABI
Prism 7700 instrument (Applied Biosystems) using a standard
curve and the relative quantification method as described in ABI
User Bulletin #2. Beta-actin was used as an internal reference
standard (Applied Biosystems product number 4310881E). T
Ag primer–probe sequences correspond to SV40 nucleotides3618 to 3698. Forward primer sequence: TTTGGGCAA-
CAAACAGTGTAGC. Probe sequence: AAGCAACTC-
CAGCCATCCATTCTTCTATGTC. Reverse primer sequence:
AATGTTTGGTTCTACAGGCTCTGC. VP1 primer–probe
sequences correspond to SV40 nucleotides 2072 to 2156.
Forward primer sequence: ATGAACACTGACCA-
CAAGGCTGT. Probe sequence: TTGGATAAGGATAATGCT-
TATCCAGTGGAGTGCT. Reverse primer sequence:
TTTCATTTTTACTTGGATCAGGAACC.
Crystal violet staining
Cells were cultured and transfected in 6-well dishes. Upon
clear visualization of cytopathic effect (7 to 10 days post-
transfection), cells were rinsed twice with PBS and fixed with
10% buffered formalin acetate for 10 min at room temperature.
Cells were then rinsed once with water and stained for 30 min
with 0.1% crystal violet solution in 10% ethanol. After rinsing 5
times with water, plates were allowed to dry overnight. To
quantify staining, 1 mL 10% acetic acid was added per well to
solubilize crystal violet. For each well, 100 μL was transferred
to a 96-well plate and the optical density was measured at
590 nm on a microplate reader (BioRad Model 5500). Values
were normalized to mock-transfected cells.
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